Healthy volunteers test new drug NTB003 for safety
Knowledge-focused
ENROLLING_BY_INVITATION
This early-stage study tests the safety of a new drug called NTB003 in 40 healthy adults aged 25 to 45. Participants receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat any …
Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC